{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:00:05Z","timestamp":1790287205726,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.htct.2026.106539","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:07:45Z","timestamp":1790284065000},"page":"106539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic factors of acute and chronic graft-versus-host disease in pediatric patients undergoing bone marrow haploidentical transplant with post-transplantation cyclophosphamide"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6856-0483","authenticated-orcid":false,"given":"Meriem","family":"Lameri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia Ben","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0820-0562","authenticated-orcid":false,"given":"Eya","family":"Ghazouani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhem Ben","family":"Fraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8614-0763","authenticated-orcid":false,"given":"Mohamed Hichem","family":"Sellami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Aissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1491-7153","authenticated-orcid":false,"given":"Yesmine","family":"Boughzala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4477-7126","authenticated-orcid":false,"given":"Houda","family":"Kaabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slama","family":"Hmida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3642-6743","authenticated-orcid":false,"given":"Monia","family":"Ouederni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6669-8275","authenticated-orcid":false,"given":"Manel","family":"Chaabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.htct.2026.106539_bib0001","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.hoc.2022.12.009","article-title":"Hematopoietic stem cell transplantation in thalassemia","volume":"37","author":"Algeri","year":"2023","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.htct.2026.106539_bib0002","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/bbmt.2001.v7.pm11215697","article-title":"Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers","volume":"7","author":"Storb","year":"2001","journal-title":"Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl"},{"issue":"4","key":"10.1016\/j.htct.2026.106539_bib0003","first-page":"30","article-title":"Outcome of allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies","volume":"8","author":"Zahid","year":"2014","journal-title":"Int J Hematol-Oncol Stem Cell Res"},{"issue":"3","key":"10.1016\/j.htct.2026.106539_bib0004","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/ehm.10.21","article-title":"Allogeneic hematopoietic cell transplantation: the state of the art","volume":"3","author":"Gyurkocza","year":"2010","journal-title":"Expert Rev Hematol"},{"issue":"2","key":"10.1016\/j.htct.2026.106539_bib0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.soncn.2009.03.004","article-title":"History of hematopoietic stem cell transplantation","volume":"25","author":"Ezzone","year":"2009","journal-title":"Semin Oncol Nurs"},{"issue":"507","key":"10.1016\/j.htct.2026.106539_bib0006","first-page":"52","article-title":"Allogreffe: nouveaut\u00e9s et perspectives","volume":"2018","author":"Le Bourgeois","year":"2018","journal-title":"Rev Fr Lab"},{"key":"10.1016\/j.htct.2026.106539_bib0007","author":"Pagliardini","year":"2018","journal-title":"Greffe allog\u00e9nique de cellules souches hematopo\u00ef\u00e9tiques utilisant un donneur haploidentique versus non apparent\u00e9 chez des patients de moins de 60 ans atteints d\u2019h\u00e9mopathies malignes: une exp\u00e9rience monocentrique de 209 malades"},{"issue":"12","key":"10.1016\/j.htct.2026.106539_bib0008","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.bbmt.2012.09.005","article-title":"Haploidentical transplantation: repurposing cyclophosphamide","volume":"18","author":"Jones","year":"2012","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"10.1016\/j.htct.2026.106539_bib0009","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.htct.2026.106539_bib0010","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"10.1016\/j.htct.2026.106539_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transpl"},{"issue":"6","key":"10.1016\/j.htct.2026.106539_bib0012","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood.V63.6.1265.1265","article-title":"Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow","volume":"63","author":"Bross","year":"1984","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.htct.2026.106539_bib0013","doi-asserted-by":"crossref","DOI":"10.2217\/ijh-2019-0006","article-title":"Outcome of donor and recipient sex match versus mismatch in stem cell transplant procedure","volume":"8","author":"Ali","year":"2019","journal-title":"Int J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.htct.2026.106539_bib0014","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2003-07-2603","article-title":"Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants","volume":"103","author":"Randolph","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.htct.2026.106539_bib0015","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2141.1990.tb06340.x","article-title":"Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation","volume":"74","author":"Flowers","year":"1990","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.htct.2026.106539_bib0016","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl"},{"issue":"2","key":"10.1016\/j.htct.2026.106539_bib0017","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","article-title":"Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.htct.2026.106539_bib0018","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia","volume":"126","author":"Ciurea","year":"2015","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.htct.2026.106539_bib0019","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2012.44.3523","article-title":"T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation","volume":"31","author":"Bashey","year":"2013","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"issue":"1","key":"10.1016\/j.htct.2026.106539_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-017-0394-2","article-title":"A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia","volume":"10","author":"Piemontese","year":"2017","journal-title":"J Hematol Oncol J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.htct.2026.106539_bib0021","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbmt.2012.08.014","article-title":"Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning","volume":"19","author":"Raiola","year":"2013","journal-title":"Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl"},{"issue":"12","key":"10.1016\/j.htct.2026.106539_bib0022","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.bbmt.2012.06.019","volume":"18","author":"Solomon","year":"2012","journal-title":"Biol Blood Marrow Transpl"},{"issue":"7","key":"10.1016\/j.htct.2026.106539_bib0023","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.bbmt.2015.03.003","article-title":"Total body irradiation-based myeloablative haploidentical stem cell transplantation is a safe and effective alternative to unrelated donor transplantation in patients without matched sibling donors","volume":"21","author":"Solomon","year":"2015","journal-title":"Biol Blood Marrow Transpl J Am Soc Blood Marrow Transpl"},{"issue":"6","key":"10.1016\/j.htct.2026.106539_bib0024","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/bloodadvances.2016002196","article-title":"Related haploidentical donors are a better choice than matched unrelated donors: point","volume":"1","author":"Fuchs","year":"2017","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.htct.2026.106539_bib0025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.patbio.2014.05.004","article-title":"Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 1)","volume":"62","author":"Blaise","year":"2014","journal-title":"Pathol Biol"},{"issue":"4","key":"10.1016\/j.htct.2026.106539_bib0026","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.patbio.2014.05.002","article-title":"Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)","volume":"62","author":"Nguyen","year":"2014","journal-title":"Pathol Biol"},{"issue":"6","key":"10.1016\/j.htct.2026.106539_bib0027","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/bmt.2016.18","article-title":"Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the worldwide network for blood and marrow transplantation group including the global survey","volume":"51","author":"Niederwieser","year":"2016","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"10.1016\/j.htct.2026.106539_bib0028","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/bmt.2017.34","article-title":"Use of haploidentical stem cell transplantation continues to increase: the 2015 European society for blood and marrow transplant activity survey report","volume":"52","author":"Passweg","year":"2017","journal-title":"Bone Marrow Transpl"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:07:49Z","timestamp":1790284069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137926002865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2531137926002865"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.106539","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors of acute and chronic graft-versus-host disease in pediatric patients undergoing bone marrow haploidentical transplant with post-transplantation cyclophosphamide","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.106539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106539"}}